Ashwani Verma
Overview
Explore the profile of Ashwani Verma including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
39
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bora N, K V, Verma A, Bharti A, Sinha M
F1000Res
. 2024 Aug;
13:787.
PMID: 39131836
Background: One of the largest hazards to human health is obesity, which is intimately related to sedentarism and physical inactivity. Understanding the perspectives and attitudes of adults with overweight or...
2.
Sinha M, Soman A, K V, Krishna Kovela R, Lakshminarayanan M, Amin R, et al.
BMJ Open
. 2022 Nov;
12(11):e059987.
PMID: 36332963
Introduction: The COVID-19 pandemic has posed an unparalleled threat to all dimensions of human health and well-being. The Pan American Health Organization has acknowledged the crucial role of rehabilitation therapies...
3.
Singh K, Verma A, Lakshminarayan M
Osong Public Health Res Perspect
. 2022 Nov;
13(5):316-327.
PMID: 36328236
The initial case of coronavirus disease 2019 (COVID-19) in India was reported on January 30, 2020, and subsequently, the number of COVID-19-infected patients surged during the first wave of April...
4.
Sharma D, Verma A, Debnath M, Ojha S, Niraula A
J Radiol Nurs
. 2022 Oct;
41(4):334-338.
PMID: 36211628
Background: Professional quality of life is one of the growing concerns among healthcare workers especially during COVID-19 pandemic. Presence and work of radiologist and medical imaging technologist for prolonged hours...
5.
Verma A, Gudi N, Yadav U, Roy M, Mahmood A, Nagaraja R, et al.
J Glob Health
. 2021 Sep;
11:04038.
PMID: 34484706
Background: By 2030, Sustainable Development Goal 3.4 aims to reduce the premature mortality caused by non-communicable diseases through prevention and treatment. Chronic obstructive pulmonary disease is the second leading cause...
6.
Gudi N, Mahmood A, Roy M, Ravishankar , Nayak P, Verma A
Can J Respir Ther
. 2021 Feb;
57:14-17.
PMID: 33542948
Background: The Sustainable Development Goals and the National Health Policy of India aim to reduce premature mortality from noncommunicable diseases (NCD) by one-third in the next decade and by 25%...
7.
Gunjawate D, Ravi R, Yerraguntla K, Rajashekhar B, Verma A
Clin Epidemiol Glob Health
. 2020 Aug;
9:110-115.
PMID: 32838065
Background: Coronavirus disease 2019 (COVID-19) has spread throughout the world and become a global pandemic. This has hampered and led to drastic changes in the functioning of healthcare services, forcing...
8.
Choudhary D, Kushwaha P, Gautam J, Kumar P, Verma A, Kumar A, et al.
Biomed Pharmacother
. 2016 Aug;
83:942-957.
PMID: 27522257
Objective: This study aims to evaluate the skeletal effects of dalbergin (DBN), isolated from Dalbergia sissoo heartwood, in ovariectomized (OVx) BALB/c mice, a postmenopausal osteoporosis model of bone loss. Methods:...
9.
Black S, Stanley W, Filipp F, Bhairo M, Verma A, Wichmann O, et al.
Bioorg Med Chem
. 2007 Nov;
16(3):1162-73.
PMID: 18024138
A series of 2- and 3-OH Nile red dyes was prepared in order to generate water-soluble probes that could be used to probe lipid binding to proteins. Various substitutions in...